Publications/White Papers

Partners4Access > Enlightened Opinion > Publications/White Papers

P4A experts regularly share their unique perspectives that inform and challenge the norm through articles and white papers.

the-ema-has-updated-its-practical-guidance-for-pharmaceutical-companies-for-procedures-related-to-brexit

The EMA has updated its practical guidance for pharmaceutical companies for procedures related to Brexit

From 30th March 2019, when the United Kingdom’s (U.K.) is expected to withdraw from the European Union (EU), all EU law will no longer apply to the U.K. The European Medicines Agency (EMA) and the European Commission have therefore published additional practical guidance to help pharmaceutical companies legally prepare for this transition. This guidance will […]

Read More

amsterdam-will-be-the-new-host-of-the-ema

Amsterdam will be the new host of the EMA

Amsterdam has been selected as the new post-Brexit home for the European Medicines Agency (EMA). It was chosen in a draw of lots between it and Milan, after three rounds of voting had failed to pick a favourite. The EMA has been located in London since its formation in 1995, where it employs around 900 […]

Read More

ema-and-eunethta-publish-a-3-year-collaboration-plan-to-improve-efficiency-and-quality

EMA and EUnetHTA publish a 3 year collaboration plan to improve efficiency and quality

The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) have finalised “a joint work plan outlining key areas of collaboration for the next three years”. The main areas of collaboration are information exchange at market entry, data generation post approval and early dialogue. These areas are expected to also provide […]

Read More

All Rights Reserved ©   Privacy   Partners 4 Access 2018